glp-1 pediatric Oral Semaglutide Shows Promise in Adolescents with Type 2 Diabetes GLP-1 weight loss drugs are

By creating an energy deficit and enhancing insulin sensitivity through weight loss, these agents may help reduce the factors that contribute to abdominal fat accumulation

#PharmaIntelligence #GenericDrugs #RegulatoryAffairs #PharmacodiaGlobal #ChinaPharma #DrugDevelopment To view or add a comment, sign in Canada Adopts ICH M13A Guideline for Some Modified Release (MR) Products Based on: Health Canada's official notice on ICH M13A implementation Link to Notice What is ICH M13A

The long-acting analoguesparticularly semaglutide and tirzepatideachieve the greatest reductions in glycated hemoglobin and body weight, while liraglutide and dulaglutide show moderate but clinically relevant benefits

The Lizard That Launched a Multi-Billion Dollar Industry From lizard venom to cutting-edge injections and pills, the GLP-1 journey has become one of the most competitive and fast-evolving stories in modern medicine

Ortega-Anaya J, Marciniak A, Jimnez-Flores R (2021) Milk fat globule membrane phospholipids modify adhesion of Lactobacillus to mucus-producing Caco-2/Goblet cells by altering the cell envelope